JP2004509645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509645A5 JP2004509645A5 JP2002530855A JP2002530855A JP2004509645A5 JP 2004509645 A5 JP2004509645 A5 JP 2004509645A5 JP 2002530855 A JP2002530855 A JP 2002530855A JP 2002530855 A JP2002530855 A JP 2002530855A JP 2004509645 A5 JP2004509645 A5 JP 2004509645A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- array
- proteins
- nuclease
- tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 description 35
- 102000004169 proteins and genes Human genes 0.000 description 32
- 108090000623 proteins and genes Proteins 0.000 description 32
- 108020004414 DNA Proteins 0.000 description 9
- 239000003550 marker Substances 0.000 description 8
- 101710163270 Nuclease Proteins 0.000 description 6
- 238000003498 protein array Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 108010037497 3'-nucleotidase Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0020357A GB0020357D0 (en) | 2000-08-17 | 2000-08-17 | Method |
| US24799500P | 2000-11-14 | 2000-11-14 | |
| PCT/GB2001/003693 WO2002027327A2 (en) | 2000-08-17 | 2001-08-17 | Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509645A JP2004509645A (ja) | 2004-04-02 |
| JP2004509645A5 true JP2004509645A5 (https=) | 2008-10-02 |
Family
ID=26244855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002530855A Pending JP2004509645A (ja) | 2000-08-17 | 2001-08-17 | 方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1326970A2 (https=) |
| JP (1) | JP2004509645A (https=) |
| KR (1) | KR20030043933A (https=) |
| CN (1) | CN1494589A (https=) |
| AU (1) | AU2001279948A1 (https=) |
| BR (1) | BR0113330A (https=) |
| CA (1) | CA2420415A1 (https=) |
| GB (1) | GB2384779B (https=) |
| IL (1) | IL154486A0 (https=) |
| WO (1) | WO2002027327A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0202018D0 (en) | 2002-01-29 | 2002-03-13 | Sense Proteomic Ltd | Tag and method |
| JP2006506447A (ja) * | 2002-10-25 | 2006-02-23 | センス プロテオミック リミテッド | Ｂｌｅ遺伝子によってコードされているタンパク質、及びブレオマイシン・ファミリー由来抗生物質の新規使用方法 |
| US20060094059A1 (en) * | 2004-09-22 | 2006-05-04 | Odyssey Thera, Inc. | Methods for identifying new drug leads and new therapeutic uses for known drugs |
| GB2460717A (en) | 2008-06-11 | 2009-12-16 | Sense Proteomic Ltd | Autoantibodies for the detection of a predisposition to Lupus |
| GB2478734A (en) | 2010-03-15 | 2011-09-21 | Sense Proteomic Ltd | Auto-antibody biomarkers of prostate cancer |
| GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2302147C (en) * | 1997-09-03 | 2008-05-13 | Biovation Limited | Methods for protein screening |
| CA2319828A1 (en) * | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
| CA2323638A1 (en) * | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
| US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| AU771262B2 (en) * | 1998-08-12 | 2004-03-18 | Eisai Inc. | Profiling and cataloging expressed protein tags |
| AU778194B2 (en) * | 1999-07-12 | 2004-11-18 | Bristol-Myers Squibb Company | C-terminal protein tagging |
| KR20020064140A (ko) * | 2000-01-31 | 2002-08-07 | 센스 프로테오믹 리미티드 | 단백질 발현 어레이의 제작 방법 |
-
2001
- 2001-08-17 AU AU2001279948A patent/AU2001279948A1/en not_active Abandoned
- 2001-08-17 JP JP2002530855A patent/JP2004509645A/ja active Pending
- 2001-08-17 CN CNA018157068A patent/CN1494589A/zh active Pending
- 2001-08-17 EP EP01958221A patent/EP1326970A2/en not_active Withdrawn
- 2001-08-17 BR BR0113330-6A patent/BR0113330A/pt not_active IP Right Cessation
- 2001-08-17 CA CA002420415A patent/CA2420415A1/en not_active Abandoned
- 2001-08-17 IL IL15448601A patent/IL154486A0/xx unknown
- 2001-08-17 KR KR10-2003-7002339A patent/KR20030043933A/ko not_active Withdrawn
- 2001-08-17 WO PCT/GB2001/003693 patent/WO2002027327A2/en not_active Ceased
- 2001-08-17 GB GB0306057A patent/GB2384779B/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN119574873A (zh) | 采用核酸编码的大分子分析 | |
| US20100203653A1 (en) | Protein G-Oligonucleotide Conjugate | |
| ATE342353T1 (de) | Abtrennung von plasmin(ogen) aus proteinlösungen | |
| JP2003525022A5 (https=) | ||
| JP2022526939A (ja) | 修飾された切断酵素、その使用、および関連キット | |
| JPH0256500A (ja) | 基底膜物質の免疫学的測定法のために好適なラミニン及びその製法 | |
| JP2004509645A5 (https=) | ||
| WO2001073126A3 (en) | Diagnostic devices containing porous material | |
| US8268570B2 (en) | Restricted access media and methods for making restricted access media | |
| WO2007124593A1 (en) | Branched peptide amplification and uses thereof | |
| Wade et al. | Use of thiazolidine-mediated ligation for site specific biotinylation of mouse EGF for biosensor immobilisation | |
| JP2000514799A (ja) | オリゴヌクレオチドリンカーおよび固定化および結合オリゴヌクレオチドを用いる技術 | |
| CN121039293A (zh) | 用于分子条形码化的组合物和方法 | |
| EP1628998A2 (en) | A tag for purification of peptides | |
| JP2005506039A5 (https=) | ||
| US20190161521A1 (en) | Antibody binding nanofibrils | |
| JPWO2004067742A1 (ja) | 切断可能な対応付け分子およびそれを用いるスクリーニング方法 | |
| CN112898172B (zh) | 可被羧肽酶酶解的双亲和功能团化合物的合成方法 | |
| Piccinni et al. | Purifying antibodies raised against Xenopus peptides | |
| KR101317321B1 (ko) | 혈청 아밀로이드 ｐ 요소 단백질의 분자각인 칩 | |
| JP2003521922A5 (https=) | ||
| CA2335335A1 (en) | Human erythrocyte differentiation related factor | |
| JP4391829B2 (ja) | 巨大分子あるいは分子または粒子の凝集体の濃化方法 | |
| DE60223937D1 (de) | Nukleinsäuren kodierend miteinander verbundene chromo/fluoreszenzdomänen und verfahren zu ihrer verwendung | |
| JPH09301995A (ja) | 新規なポリペプチド及びそれを用いる生体成分測定方法 |